文献速递甲状腺核医学肿瘤 PET/CT

甲状旁腺影像学

Parathyroid Imaging.
PubMed 文献 · Semin Nucl Med · 2023-03-14

原发性甲状旁腺功能亢进症(1° HPT)通常由甲状旁腺腺瘤自主分泌甲状旁腺激素所致,应尽可能行甲状旁腺切除术;术前准确定位对手术规划至关重要,颈部超声常作为一线定位方法,随后尽可能行99mTc-甲氧基异丁基异腈闪烁显像联合SPECT/CT,18F-氟胆碱PET/CT是检测甲状旁腺腺瘤最敏感的方法。继发性甲状旁腺功能亢进症(2° HPT)通常不将甲状旁腺切除术作为管理的一部分,故不常规行甲状旁腺影像学检查;三发性甲状旁腺功能亢进症(3° HPT)常行全或次全甲状旁腺切除术,18F-FCH PET/CT是多腺体病变最敏感的检查方式,是3° HPT患者的首选影像技术,但其成本和可及性可能限制其在该情况下的广泛使用。

要点

  • 1° HPT导致高钙血症、肾结石和/或骨质疏松时应尽可能行甲状旁腺切除术。
  • 颈部超声常作为1° HPT甲状旁腺腺瘤定位的一线方法,随后尽可能行99mTc-sestamibi闪烁显像联合SPECT/CT。
  • 18F-FCH PET/CT是检测甲状旁腺腺瘤最敏感的方法,在多腺体病变中也是最敏感的检查方式。

核心结论

  • 1° HPT导致高钙血症、肾结石和/或骨质疏松时应尽可能行甲状旁腺切除术。
  • 术前准确定位甲状旁腺腺瘤对手术规划至关重要,尤其是行微创手术时。
  • 18F-FCH PET/CT是检测甲状旁腺腺瘤最敏感的方法。
  • 18F-FCH PET/CT是多腺体病变最敏感的检查方式,是3° HPT患者的首选影像技术。

研究设计与样本

  • 本文为综述,检索范围原文未报告。

主要发现

  • 1° HPT通常由单个或多个甲状旁腺腺瘤自主分泌甲状旁腺激素所致。
  • 颈部超声常作为甲状旁腺腺瘤定位的一线方法,随后尽可能行99mTc-sestamibi闪烁显像联合SPECT/CT。
  • 4D-CT可作为99mTc-sestamibi闪烁显像的替代方案。
  • 18F-FCH PET/CT可最终与4D-CT联合以提高诊断性能,尽管这会增加患者的剂量暴露。
  • 2° HPT患者通常不将甲状旁腺切除术作为管理的一部分,故不常规行甲状旁腺影像学检查;3° HPT患者常行全或次全甲状旁腺切除术,定位功能亢进的腺体是手术规划的重要辅助。

关键数值与推荐

  • 1° HPT导致高钙血症、肾结石和/或骨质疏松时应尽可能行甲状旁腺切除术。
  • 颈部超声常作为甲状旁腺腺瘤定位的一线方法,随后尽可能行99mTc-sestamibi闪烁显像联合SPECT/CT。
  • 18F-FCH PET/CT是检测甲状旁腺腺瘤最敏感的方法。
  • 18F-FCH PET/CT是多腺体病变最敏感的检查方式,是3° HPT患者的首选影像技术,但其成本和可及性可能限制其在该情况下的广泛使用。

临床怎么用

  • 1° HPT导致高钙血症、肾结石和/或骨质疏松时应尽可能行甲状旁腺切除术。
  • 1° HPT术前定位常先行颈部超声,随后尽可能行99mTc-sestamibi闪烁显像联合SPECT/CT。
  • 4D-CT可作为99mTc-sestamibi闪烁显像的替代方案。
  • 18F-FCH PET/CT可最终与4D-CT联合以提高诊断性能,尽管这会增加患者的剂量暴露。
  • 3° HPT患者行全或次全甲状旁腺切除术前,18F-FCH PET/CT是多腺体病变最敏感的检查方式,是首选影像技术。

局限性

  • 18F-FCH PET/CT的成本和可及性可能限制其在该情况下的广泛使用。
  • 18F-FCH PET/CT与4D-CT联合虽可提高诊断性能,但会增加患者的剂量暴露。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Primary hyperparathyroidism (1° HPT) is a relatively common endocrine disorder usually caused by autonomous secretion of parathormone by one or several parathyroid adenomas. 1° HPT causing hypercalcemia, kidney stones and/or osteoporosis should be treated whenever possible by parathyroidectomy. Accurate preoperative location of parathyroid adenomas is crucial for surgery planning, mostly when performing minimally invasive surgery. Cervical ultrasonography (US) is usually performed to localize parathyroid adenomas as a first intention, followed by 99mTc- sestamibi scintigraphy with SPECT/CT whenever possible. 4D-CT is a possible alternative to 99mTc- sestamibi scintigraphy. Recently, 18F-fluorocholine positron emission tomography/computed tomography (18F-FCH PET/CT) has made its way in the clinics as it is the most sensitive method for parathyroid adenoma detection. It can eventually be combined to 4D-CT to increase its diagnostic performance, although this results in higher dose exposure to the patient. Other forms of hyperparathyroidism consist in secondary (2° HPT) and tertiary hyperparathyroidism (3° HPT). As parathyroidectomy is not usually part of the management of patients with 2° HPT, parathyroid imaging is not routinely performed in these patients. In patients with 3° HPT, total or subtotal parathyroidectomy is often performed. Localization of hyperfunctional glands is an important aid to surgery planning. As 18F-FCH PET/CT is the most sensitive modality in multigland disease, it is the preferred imaging technic in 3° HPT patients, although its cost and availability may limit its widespread use in this setting.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Lalonde MN, Correia RD, Syktiotis GP, et al. Parathyroid Imaging. Semin Nucl Med. 2023. PMID: 36922339. doi:10.1053/j.semnuclmed.2023.02.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。